{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:51:34Z","timestamp":1794621094701,"version":"4.9.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e26619","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T02:51:11Z","timestamp":1708397471000},"page":"e26619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The association between high mobility group box 1 (HMGB1) and Interleukin-18 (IL-18) serum concentrations in COVID-19 inpatients"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3149-5416","authenticated-orcid":false,"given":"Sri","family":"Wulandari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titik","family":"Nuryastuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida Nur","family":"Oktoviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3028-2761","authenticated-orcid":false,"given":"Marselinus Edwin Widyanto","family":"Daniwijaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endah","family":"Supriyati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eggi","family":"Arguni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hartono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-4575","authenticated-orcid":false,"given":"Tri","family":"Wibawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7942","key":"10.1016\/j.heliyon.2024.e26619_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-022-05522-2","article-title":"The WHO estimates of excess mortality associated with the COVID-19 pandemic","volume":"613","author":"Msemburi","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26619_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1108\/JHR-06-2020-0229","article-title":"COVID-19 case fatality rates across Southeast Asian countries (SEA): a preliminary estimate using a simple linear regression model","volume":"35","author":"Puno","year":"2020","journal-title":"J Heal Res"},{"key":"10.1016\/j.heliyon.2024.e26619_bib3","series-title":"Indonesia COVID-19 Situation Report: October-December 2022-Indonesia|ReliefWeb","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e26619_bib4","series-title":"Coronavirus (COVID-19) Dashboard with Vaccination Data","first-page":"1","year":"2023"},{"key":"10.1016\/j.heliyon.2024.e26619_bib5","series-title":"Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals","year":"2023"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26619_bib6","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1002\/mco2.228","article-title":"COVID-19 in early 2023: Structure, replication mechanism, variants of SARS-CoV-2, diagnostic tests, and vaccine & drug development studies","volume":"4","author":"Polato\u011flu","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.heliyon.2024.e26619_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2021-216949","article-title":"Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data","volume":"77","author":"Hedberg","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.heliyon.2024.e26619_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-2600(20)30527-0","article-title":"Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study","volume":"9","author":"Piroth","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2024.e26619_bib9","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.immuni.2021.05.002","article-title":"Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia","volume":"54","author":"Kreutmair","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2024.e26619_bib10","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26619_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41435-021-00140-w","article-title":"Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome\u2014with a preliminary reference to SARS-CoV-2 pneumonia","volume":"22","author":"Land","year":"2021","journal-title":"Gene Immun."},{"key":"10.1016\/j.heliyon.2024.e26619_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172487","article-title":"Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: updates on receptor signalling","volume":"858","author":"Paudel","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e26619_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1089\/ars.2019.7818","article-title":"The role of HMGB1, a damage-associated molecular pattern molecule, in the pathogenesis of lung diseases","volume":"31","author":"Wang","year":"2019","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.heliyon.2024.e26619_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00246-18","article-title":"Serum high-mobility-group box 1 as a biomarker and a therapeutic target during respiratory virus infections","volume":"9","author":"Patel","year":"2018","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26619_bib15","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.4110\/in.2023.23.e26","article-title":"SARS-CoV-2 infection induces HMGB1 secretion through post-translational modification and PANoptosis","volume":"23","author":"Kwak","year":"2023","journal-title":"Immune Netw"},{"key":"10.1016\/j.heliyon.2024.e26619_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000508291","article-title":"HMGB1: a possible crucial therapeutic target for COVID-19?","volume":"93","author":"Street","year":"2020","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.heliyon.2024.e26619_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05672","article-title":"HMGB1 as a potential biomarker and therapeutic target for severe COVID-19","volume":"6","author":"Chen","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e26619_bib18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41423-020-0492-x","article-title":"Elevated serum levels of S100A8\/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients","volume":"17","author":"Chen","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.heliyon.2024.e26619_bib19","article-title":"Oxidative stress and inflammatory markers in patients with COVID-19: potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity","volume":"104","author":"Passos","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26619_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4269\/ajtmh.21-0165","article-title":"High mobility group box 1 and interleukin 6 at intensive care unit admission as biomarkers in critically Ill COVID-19 patients","volume":"105","author":"Sivakorn","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2024.e26619_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.heliyon.2024.e26619_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2021.03.002","article-title":"COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?","volume":"232","author":"Ombrello","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.heliyon.2024.e26619_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155302","article-title":"Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19","volume":"137","author":"Sat\u0131\u015f","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.heliyon.2024.e26619_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1721727X221140661","article-title":"Pyroptosis in the lung and spleen of patients died from COVID-19","volume":"20","author":"Tong","year":"2022","journal-title":"Eur. J. Inflamm."},{"key":"10.1016\/j.heliyon.2024.e26619_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s10020-020-00172-4","article-title":"Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?","volume":"26","author":"Andersson","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e26619_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.7314\/APJCP.2012.13.4.1365","article-title":"HMGB1 promotes the synthesis of pro-IL-1\u03b2 and pro-IL-18 by activation of p38 MAPK and NF-\u03baB through receptors for advanced glycation end-products in macrophages","volume":"13","author":"He","year":"2012","journal-title":"Asian Pacific J Cancer Prev"},{"key":"10.1016\/j.heliyon.2024.e26619_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26619_bib28","first-page":"69","article-title":"Statistics corner: a guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med. J."},{"key":"10.1016\/j.heliyon.2024.e26619_bib29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcv.2012.07.010","article-title":"Elevated serum levels of high mobility group box 1 (HMGB1) protein in dengue-infected patients are associated with disease symptoms and secondary infection","volume":"55","author":"Allonso","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.heliyon.2024.e26619_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10787-022-00988-y","article-title":"High-mobility group box 1 (HMGB1) in COVID-19 extrapolation of dangerous liaisons","volume":"30","author":"Al-kuraishy","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e26619_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107061","article-title":"Elevated HMGB1 and sRAGE levels in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients","volume":"32","author":"Chu","year":"2023","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.heliyon.2024.e26619_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3892\/etm.2013.1095","article-title":"Correlation between serum high-mobility group box - 1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease","volume":"6","author":"Yao","year":"2013","journal-title":"Exp dan Ther Med"},{"key":"10.1016\/j.heliyon.2024.e26619_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","article-title":"HMGB1 in health and disease","volume":"40","author":"Kang","year":"2014","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.heliyon.2024.e26619_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16197-5","article-title":"Dengue fatal cases present virus-specific HMGB1 response in peripheral organs","volume":"7","author":"Oliveira","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e26619_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041932","article-title":"Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells","volume":"7","author":"Ong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e26619_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155713","article-title":"The relationship between changes in IL-2\/IL-18 and liver enzyme with dengue severity","volume":"148","author":"Patra","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.heliyon.2024.e26619_bib37","first-page":"2021","article-title":"Serum IL-18 is a potential biomarker for predicting severe Dengue disease progression","author":"Nanda","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.heliyon.2024.e26619_bib38","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2217\/fmb-2022-0057","article-title":"Elevated IL-18 predicts poor prognosis in critically ill COVID-19 patients at a Brazilian hospital in 2020-21","volume":"17","author":"Coutinho","year":"2022","journal-title":"Future Microbiol."},{"key":"10.1016\/j.heliyon.2024.e26619_bib39","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/infdis\/jiab005","article-title":"Early differences in cytokine production by severity of coronavirus disease 2019","volume":"223","author":"Tjan","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e26619_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/03946320231163681","article-title":"Patterns of cytokine and chemokine expression in peripheral blood of patients with COVID-19 associated with disease severity","volume":"37","author":"Trifonova","year":"2023","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26619_bib41","series-title":"Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07\/MenKes\/413\/2020 Tentang Pedoman Pencegahan Dan Pengendalian Coronavirus Disease 2019 (Covid-19)","author":"Kementerian Kesehatan","year":"2020"},{"issue":"26","key":"10.1016\/j.heliyon.2024.e26619_bib42","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMc2108120","article-title":"Severity of SARS-CoV-2 reinfections as compared with primary infections","volume":"385","author":"Abu-Raddad","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e26619_bib43","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.3390\/ijerph20043335","article-title":"Severity and outcomes of SARS-CoV-2 reinfection compared with primary infection: a systematic review and meta-analysis","volume":"20","author":"Deng","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.heliyon.2024.e26619_bib44","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41598-022-25908-6","article-title":"Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic","volume":"13","author":"Guedes","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e26619_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713164","article-title":"Serum high-mobility group box 1 and heme oxygenase-1 as biomarkers in COVID-19 patients at hospital admission","volume":"24","author":"Grigorov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e26619_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26619_bib47","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e26619_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41392-023-01368-w","article-title":"SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy","volume":"8","author":"Liang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.heliyon.2024.e26619_bib49","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3389\/fimmu.2020.01580","article-title":"Severe COVID-19: NLRP3 inflammasome dysregulated","volume":"11","author":"van den Berg","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26619_bib50","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1189\/jlb.0908548","article-title":"The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation","volume":"86","author":"Hreggvidsdottir","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"7269","key":"10.1016\/j.heliyon.2024.e26619_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature08512","article-title":"HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses","volume":"462","author":"Yanai","year":"2009","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.heliyon.2024.e26619_bib52","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1128\/JVI.00789-12","article-title":"HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication","volume":"86","author":"Moisy","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.heliyon.2024.e26619_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s10020-019-0081-6","article-title":"Inhibition of HMGB1\/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation","volume":"25","author":"Yang","year":"2019","journal-title":"Mol. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e26619_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009037","article-title":"On the whereabouts of SARS-CoV-2 in the human body: a systematic review","volume":"16","author":"Trypsteen","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2024.e26619_bib55","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/cells10123323","article-title":"Post-translational modification of HMGB1 disulfide bonds in stimulating and inhibiting inflammation","volume":"10","author":"Andersson","year":"2021","journal-title":"Cells"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024026501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024026501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:26:10Z","timestamp":1769045170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024026501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024026501"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26619","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between high mobility group box 1 (HMGB1) and Interleukin-18 (IL-18) serum concentrations in COVID-19 inpatients","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e26619"}}